Investigational Drug Service

Atlanta, Georgia 30322

0 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Advanced Cancers, Advanced Gastric Cancer, Advanced/Metastatic Non-Small Cell Lung Cancer, Gastrointestinal Stromal Tumor, Hemophilia A, Hemophilia B, Hepatocellular Carcinoma, Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, Metastatic Renal Cell Cancer, Non-Small Cell Lung Cancer

Studies at this site

• A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%) — Completed
• Hepatic Impairment Study for Lorlatinib in Cancer Patients — Stopped early
• A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. — Completed